Biotech · Private company · San Carlos, CA, US
TwoStep Therapeutics, Inc.
Track this companyFree. Adds TwoStep Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- TS-104Phase 1 · NSCLC (Non-small Cell Lung Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid TumorsPHASE1 · RECRUITING · started Sep 2, 2026ClinicalTrials.gov NCT07814248 · fetched Nov 12, 2026
NIH awards1
- Developing a broadly applicable targeted peptide-drug conjugate for the treatment of solid tumorsFiscal year 2026 · $1.3MNIH RePORTER 1R44CA306597-01A1 · fetched Nov 12, 2026